- Home
- XERS vs GAIN Comparison
XERS vs GAIN Comparison
Compare XERS & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- GAIN
- Stock Information
- Founded
- XERS 2005
- GAIN 2005
- Country
- XERS United States
- GAIN United States
- Employees
- XERS N/A
- GAIN N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- GAIN Finance: Consumer Services
- Sector
- XERS Health Care
- GAIN Finance
- Exchange
- XERS Nasdaq
- GAIN Nasdaq
- Market Cap
- XERS 628.7M
- GAIN 550.0M
- IPO Year
- XERS 2018
- GAIN 2005
- Fundamental
- Price
- XERS $5.05
- GAIN $15.29
- Analyst Decision
- XERS Strong Buy
- GAIN Hold
- Analyst Count
- XERS 6
- GAIN 2
- Target Price
- XERS $6.25
- GAIN $13.50
- AVG Volume (30 Days)
- XERS 2.1M
- GAIN 141.2K
- Earning Date
- XERS 05-08-2025
- GAIN 05-13-2025
- Dividend Yield
- XERS N/A
- GAIN 9.80%
- EPS Growth
- XERS N/A
- GAIN N/A
- EPS
- XERS N/A
- GAIN 1.78
- Revenue
- XERS $222,551,000.00
- GAIN $93,662,000.00
- Revenue This Year
- XERS $33.96
- GAIN $18.70
- Revenue Next Year
- XERS $19.87
- GAIN $1.32
- P/E Ratio
- XERS N/A
- GAIN $8.60
- Revenue Growth
- XERS 29.88
- GAIN 7.28
- 52 Week Low
- XERS $2.03
- GAIN $11.42
- 52 Week High
- XERS $6.07
- GAIN $15.32
- Technical
- Relative Strength Index (RSI)
- XERS 54.35
- GAIN 66.89
- Support Level
- XERS $4.71
- GAIN $14.51
- Resistance Level
- XERS $5.09
- GAIN $15.25
- Average True Range (ATR)
- XERS 0.22
- GAIN 0.24
- MACD
- XERS -0.00
- GAIN 0.03
- Stochastic Oscillator
- XERS 58.93
- GAIN 82.40
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.